Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

General Updates | A holistic approach to R/R multiple myeloma

Ezzat El Hassadi • 20 Oct 2022
General Updates
Multiple Myeloma

Ezzat El Hassadi, MD, University Hospital Waterford, Waterford, Ireland, emphasizes the importance of using a holistic approach to treat patients with relapsed/refractory (R/R) multiple myeloma, commenting on infection prevention and management, and improving access to clinical trials and novel agents to further improve the management of multiple myeloma in Ireland. This interview was recorded virtually.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Ezzat El Hassadi

3:12
Current challenges in treatment availability for multiple myeloma in Ireland
Ezzat El Hassadi • 20 Oct 2022
3:13
How to optimally sequence agents in the expanding treatment armamentarium of multiple myeloma
Ezzat El Hassadi • 20 Oct 2022
1:23
Treatment approach for multiple myeloma with CNS relapse
Ezzat El Hassadi • 20 Oct 2022
4:08
Factors to consider when approaching R/R multiple myeloma
Ezzat El Hassadi • 20 Oct 2022

Related Videos

1:47
Looking forward to the Miami Myeloma MRD Virtual Meeting 2024
Ola Landgren • 13 Apr 2024
2:27
The encouraging results of the LINKER-MM1 trial: safety and efficacy of linvoseltamab in R/R myeloma
Faith Davies • 9 Apr 2024
0:37
Upcoming studies investigating linvoseltamab in myeloma
Faith Davies • 9 Apr 2024
3:23
Molecular characteristics associated with increased risk of disease progression in SMM
Mark Bustoros • 27 Sep 2023
The content of VJHemOnc is intended for healthcare professionals